Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02455050 · ClinicalTrials.gov registry record · Phase 3
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
A Phase 3 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 79
- Enrollment target
NCT02455050: Completed Phase 3 study, sponsored by Allergan.
NCT02455050 is a Phase 3 study that has completed, run by Allergan. The registered enrollment target is 79 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02455050, a Phase 3 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 79 participants
- Enrollment target
Study Summary
A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.
Primary Outcome
Tolerability was assessed using an 8-item survey consisting of 4 positive questions: comfort, soothing, moistening/lubricating and vision clarity and 4 negative questions: stickiness, blur, burning/stinging and discomfort. Participants were instructed to think about their experience over the past week and place a vertical line on the line that best captured how they felt the first 30 minutes after the study drops were administered using the scale: 0 far left of the line to 100 far right on the l
Interventions
- DRUG Carboxymethylcellulose Sodium Based Eye Drops
- DRUG Systane® Gel Drops
- DRUG Genteal® Lubricant Gel Drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-08 |
| Phase | Phase 3 |
What the finished NCT02455050 record still lists
NCT02455050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 3 interventions - of which Carboxymethylcellulose Sodium Based Eye Drops is the first listed.
NCT02455050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02455050 about?
NCT02455050 is a clinical study titled "A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief". A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.
What is the current status of trial NCT02455050?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 79 participants. The study started on 2014-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02455050?
The interventions under investigation include: Carboxymethylcellulose Sodium Based Eye Drops (DRUG), Systane® Gel Drops (DRUG), Genteal® Lubricant Gel Drops (DRUG).
Who is sponsoring clinical trial NCT02455050?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02455050's enrollment target sits among peer trials
79 1768th of 2000 higher than 232 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia